We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13.1B
AUM Growth
+$754M
(+6.1%)
Cap. Flow
+$1.16B
Cap. Flow
% of AUM
8.89%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
1,188
New
182
Increased
340
Reduced
340
Closed
221
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$323M |
| 3 |
Amazon
AMZN
|
+$133M |
| 4 |
UnitedHealth
UNH
|
+$97.5M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$86.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$89.2M |
| 2 |
ExxonMobil
XOM
|
+$83.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$83.1M |
| 4 |
CVS Health
CVS
|
+$82.2M |
| 5 |
Eli Lilly
LLY
|
+$66.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.23% |
| 2 | Healthcare | 11.42% |
| 3 | Energy | 7.9% |
| 4 | Consumer Discretionary | 6.67% |
| 5 | Financials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOGL
626
DELISTED
Golden Ocean Group
GOGL
| $407K | ﹤0.01% |
51,676
+49,855
| +2,738% | +$374K |
|
627
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.69B
| $404K | ﹤0.01% |
11,864
| – | – |
|
628
Schwab US REIT ETF
SCHH
$11.7B
| $403K | ﹤0.01% |
22,645
| – | – |
|
629
Blackstone
BX
$104B
| $402K | ﹤0.01% |
+3,750
| New | +$390K |
|
630
West Pharmaceutical
WST
$23.1B
| $398K | ﹤0.01% |
1,061
-3,585
| -77% | -$1.39M |
|
631
iShares MSCI USA Value Factor ETF
VLUE
$9.4B
| $390K | ﹤0.01% |
4,289
-74
| -2% | -$6.97K |
|
632
Valmont Industries
VMI
$9.44B
| $388K | ﹤0.01% |
1,614
-128
| -7% | -$32.9K |
|
633
Atlassian
TEAM
$22B
| $384K | ﹤0.01% |
+1,907
| New | +$362K |
|
634
State Street SPDR S&P Bank ETF
KBE
$1.64B
| $384K | ﹤0.01% |
10,417
| – | – |
|
635
Arm
ARM
$278B
| $378K | ﹤0.01% |
+7,058
| New | +$390K |
|
636
iShares US Financials ETF
IYF
$4.39B
| $376K | ﹤0.01% |
4,996
| – | – |
|
637
Denison Mines
DNN
$2.63B
| $373K | ﹤0.01% |
226,092
-153,557
| -40% | -$212K |
|
638
Nu Holdings
NU
$68.1B
| $368K | ﹤0.01% |
50,719
-16,522
| -25% | -$124K |
|
639
Darling Ingredients
DAR
$9.93B
| $365K | ﹤0.01% |
+6,988
| New | +$437K |
|
640
Sunstone Hotel Investors
SHO
$2.19B
| $350K | ﹤0.01% |
37,400
+23,700
| +173% | +$224K |
|
641
Teledyne Technologies
TDY
$30.4B
| $349K | ﹤0.01% |
855
-2,671
| -76% | -$1.08M |
|
642
Affirm
AFRM
$23.5B
| $347K | ﹤0.01% |
16,314
-7,963
| -33% | -$146K |
|
643
Synopsys
SNPS
$71.5B
| $347K | ﹤0.01% |
+756
| New | +$338K |
|
644
VanEck Oil Services ETF
OIH
$2.06B
| $343K | ﹤0.01% |
995
| – | – |
|
645
Xenon Pharmaceuticals
XENE
$6.32B
| $342K | ﹤0.01% |
10,000
+3,000
| +43% | +$112K |
|
646
PIMCO Dynamic Income Fund
PDI
$7.4B
| $340K | ﹤0.01% |
19,659
-2,450
| -11% | -$45.1K |
|
647
Open Text
OTEX
$5.43B
| $338K | ﹤0.01% |
+9,623
| New | +$377K |
|
648
Invesco
IVZ
$13.3B
| $326K | ﹤0.01% |
22,424
-200
| -0.9% | -$3.22K |
|
649
iShares China Large-Cap ETF
FXI
$4.31B
| $325K | ﹤0.01% |
12,247
+3,147
| +35% | +$86.9K |
|
|
APLS
650
DELISTED
Apellis Pharmaceuticals
APLS
| $323K | ﹤0.01% |
+8,500
| New | +$373K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q3 2023 Portfolio in Review
As of Q3 2023, Natixis held 1,188 positions worth $13.1B, up 6.1% from $12.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Natixis deployed $1.16B of net new capital in Q3 2023, opening 182 new positions and adding to 340 existing holdings. Its largest new stake was Oneok: 965,015 shares worth $61.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $89.2M trimmed.
- Natixis's largest Q3 2023 buy was Oneok: 965,015 shares worth $61.2M.
- Natixis added most to Apple in Q3 2023, an estimated $379M increase.
- Natixis's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $89.2M.
- Natixis fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $83.1M.
- Natixis's ten largest holdings make up 38% of its $13.1B portfolio in Q3 2023.
- Natixis opened 182 new positions and closed 221 in Q3 2023.
- Natixis's portfolio value rose 6.1% quarter-over-quarter to $13.1B.
Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.